NYSE:ELV - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	194,227	9,913	9,205	10,772	6
12/31/2025	182,497	9,070	9,090	9,869	14
12/31/2024	171,663	8,056	9,763	8,467	15
3/31/2024	171,745	6,244	2,296	3,570	N/A
12/31/2023	171,340	5,987	6,765	8,061	N/A
9/30/2023	168,626	6,127	8,246	9,514	N/A
6/30/2023	165,716	6,441	10,571	11,825	N/A
3/31/2023	160,676	6,094	11,128	12,327	N/A
12/31/2022	156,599	5,894	7,247	8,399	N/A
9/30/2022	153,251	6,166	10,395	11,589	N/A
6/30/2022	149,134	6,072	8,022	9,169	N/A
3/31/2022	144,353	6,228	7,263	8,400	N/A
12/31/2021	138,643	6,158	7,277	8,364	N/A
9/30/2021	133,883	5,518	9,480	10,505	N/A
6/30/2021	129,219	4,231	5,778	6,851	N/A
3/31/2021	124,632	4,714	9,657	10,678	N/A
12/31/2020	121,868	4,572	9,667	10,688	N/A
9/30/2020	117,449	4,955	7,108	8,202	N/A
6/30/2020	112,965	5,916	9,960	11,019	N/A
3/31/2020	109,167	4,779	5,899	6,946	N/A
12/31/2019	104,212	4,807	4,984	6,061	N/A
9/30/2019	100,165	4,298	4,151	5,197	N/A
6/30/2019	96,742	4,074	3,007	4,137	N/A
3/31/2019	94,220	3,989	2,018	3,242	N/A
12/31/2018	92,091	3,750	2,619	3,827	N/A
9/30/2018	91,409	4,556	891	2,063	N/A
6/30/2018	90,584	4,344	2,825	3,861	N/A
3/31/2018	90,061	4,145	2,822	3,712	N/A
12/31/2017	90,049	3,843	N/A	4,185	N/A
9/30/2017	89,055	2,980	N/A	5,763	N/A
6/30/2017	88,038	2,851	N/A	4,322	N/A
3/31/2017	87,083	2,777	N/A	4,599	N/A
12/31/2016	84,862	2,470	N/A	3,270	N/A
9/30/2016	83,364	2,282	N/A	3,943	N/A
6/30/2016	81,866	2,319	N/A	3,322	N/A
3/31/2016	80,412	2,398	N/A	3,825	N/A
12/31/2015	79,158	2,560	N/A	4,212	N/A
9/30/2015	77,959	2,886	N/A	3,472	N/A
6/30/2015	76,605	2,862	N/A	3,734	N/A
3/31/2015	75,066	2,734	N/A	3,632	N/A
12/31/2014	73,886	2,560	N/A	3,369	N/A
9/30/2014	72,792	2,362	N/A	3,337	N/A
6/30/2014	72,090	2,385	N/A	4,129	N/A
3/31/2014	71,307	2,453	N/A	3,483	N/A
12/31/2013	71,024	2,634	N/A	3,052	N/A
9/30/2013	68,443	2,785	N/A	3,539	N/A

애널리스트 미래 성장 예측

수입 대 저축률: ELV 의 연간 예상 수익 증가율( 12.2% )이 saving rate( 2.4% 보다 높습니다. ).

수익 vs 시장: ELV 의 연간 수익( 12.2% ) US 시장( 14.9% 보다 느리게 성장할 것으로 예상됩니다. 14.9% 연간).

고성장 수익: ELV 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: ELV 의 수익(연간 5.1% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: ELV 의 수익(연간 5.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: ELV 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 20.1 %)

Elevance Health 미래 성장

Future 기준 확인 2/6

주요 정보

최근 미래 성장 업데이트

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023

Elevance Health Inc. Provides Earnings Guidance for Full Year 2022

Recent updates

Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)

Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Upcoming dividend of US$1.63 per share

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

Insider recently sold US$6.8m worth of stock

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

First quarter dividend of US$1.63 announced

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024

StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc.

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Elevance: A Healthy Dose Of Dividend Growth

Insider recently sold US$1.2m worth of stock

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Insider notifies of intention to sell stock

Upcoming dividend of US$1.63 per share

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health, Inc., Annual General Meeting, May 15, 2024

Fourth quarter dividend increased to US$1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024

Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Insider notifies of intention to sell stock

Upcoming dividend of US$1.48 per share at 1.2% yield

A Look At Elevance's Margin Dynamics

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Third quarter 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health: A High Conviction Defensive Blue Chip Buy

Elevance Health, Inc. to Report Q3, 2023 Results on Oct 18, 2023

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Elevance: Pave The Way For The Next UnitedHealth

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Here's The Price I Would Buy Elevance Health Stock

Upcoming dividend of US$1.48 per share at 1.3% yield

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Elevance Health, Inc. Announces Executive Changes

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Elevance Health: Beaten Down Share Price Offers Solid Potential

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Elevance Health, Inc. to Report Q2, 2023 Results on Jul 19, 2023

Elevance Health: A Critical Update (Rating Downgrade)

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Upcoming dividend of US$1.48 per share at 1.3% yield

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Upcoming dividend of US$1.48 per share at 1.3% yield

Elevance Health, Inc., Annual General Meeting, May 10, 2023

Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Elevance Health Inc. (NYSE:ELV) completed the acquisition of BioPlus Specialty Pharmacy Services, LLC from CarepathRx.

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Elevance Health: Attractive On Its Expansion Catalysts